{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T21:50:08Z","timestamp":1786571408762,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.humimm.2018.03.004","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T17:26:50Z","timestamp":1521739610000},"page":"413-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Correlations between donor-specific antibodies and non-adherence with chronic active antibody-mediated rejection phenotypes and their impact on kidney graft survival"],"prefix":"10.1016","volume":"79","author":[{"given":"Jorge","family":"Malheiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Tafulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon\u00eddio","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La Salete","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Pedroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idalina","family":"Beir\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio","family":"Castro-Henriques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio","family":"Cabrita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2018.03.004_b0005","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal","volume":"11","author":"Lamb","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2018.03.004_b0010","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-6143.2008.02519.x","article-title":"Identifying specific causes of kidney allograft loss","volume":"9","author":"El-Zoghby","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2018.03.004_b0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/TP.0b013e3181e065de","article-title":"Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure","volume":"90","author":"Gaston","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2018.03.004_b0020","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellares","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2018.03.004_b0025","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1111\/j.1600-6143.2009.02799.x","article-title":"Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure","volume":"9","author":"Einecke","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2018.03.004_b0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/ajt.14107","article-title":"The banff 2015 kidney meeting report: current challenges in rejection classification and prospects for adopting molecular pathology","volume":"17","author":"Loupy","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2018.03.004_b0035","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/TP.0b013e3181efcffd","article-title":"Determinants of long-term graft outcome in transplant glomerulopathy","volume":"90","author":"John","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2018.03.004_b0040","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1600-6143.2009.02985.x","article-title":"Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation","volume":"10","author":"Gloor","year":"2010","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2018.03.004_b0045","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.TP.0000442513.27641.7e","article-title":"Histologic phenotype on 1-year posttransplantation biopsy and allograft survival in HLA-incompatible kidney transplants","volume":"97","author":"Sharif","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2018.03.004_b0050","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1111\/j.1600-6143.2012.04251.x","article-title":"Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection","volume":"12","author":"Ginevri","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2018.03.004_b0055","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1111\/ajt.14466","article-title":"Utility of protocol kidney biopsies for de novo donor-specific antibodies","volume":"17","author":"Parajuli","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2018.03.004_b0060","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2215\/CJN.04240413","article-title":"The clinical and genomic significance of donor-specific antibody-positive\/C4d-negative and donor-specific antibody-negative\/C4d-negative transplant glomerulopathy","volume":"8","author":"Hayde","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.humimm.2018.03.004_b0065","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.humimm.2011.02.002","article-title":"Donor human leukocyte antigen specific antibodies predict development and define prognosis in transplant glomerulopathy","volume":"72","author":"Eng","year":"2011","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2018.03.004_b0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/TP.0000000000000310","article-title":"Donor-specific antibodies, C4d and their relationship with the prognosis of transplant glomerulopathy","volume":"99","author":"Lesage","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2018.03.004_b0075","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/ki.2015.288","article-title":"Development and validation of a prognostic index for allograft outcome in kidney recipients with transplant glomerulopathy","volume":"89","author":"Patri","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.humimm.2018.03.004_b0080","article-title":"Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial","author":"Moreso","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2018.03.004_b0085","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2018.03.004_b0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.humimm.2018.03.004_b0095","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/CIRCRESAHA.117.306340","article-title":"Determinants and Outcomes of Accelerated Arteriosclerosis: Major Impact of Circulating Antibodies","volume":"117","author":"Loupy","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.humimm.2018.03.004_b0100","article-title":"T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts","author":"Lefaucheur","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2018.03.004_b0105","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1681\/ASN.2013111149","article-title":"Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection","volume":"25","author":"Loupy","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.humimm.2018.03.004_b0110","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/TP.0b013e31827d62e3","article-title":"Incidence and impact of de novo donor-specific alloantibody in primary renal allografts","volume":"95","author":"Everly","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2018.03.004_b0115","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2018.03.004_b0120","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1111\/ajt.13347","article-title":"Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2018.03.004_b0125","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/ki.2011.194","article-title":"Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy","volume":"80","author":"Baid-Agrawal","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.humimm.2018.03.004_b0130","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1681\/ASN.2016070756","article-title":"The emerging importance of non-HLA autoantibodies in kidney transplant complications","volume":"28","author":"Cardinal","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.humimm.2018.03.004_b0135","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.2215\/CJN.00260112","article-title":"Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy","volume":"7","author":"Del Bello","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.humimm.2018.03.004_b0140","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/ndt\/gfw041","article-title":"Dynamics and epitope specificity of anti-human leukocyte antibodies following renal allograft nephrectomy","volume":"31","author":"Lachmann","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.humimm.2018.03.004_b0145","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.kint.2016.10.040","article-title":"Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent\/recurrent versus de novo donor-specific antibodies","volume":"91","author":"Haas","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.humimm.2018.03.004_b0150","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.humimm.2018.03.004_b0155","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/ajt.14136","article-title":"Hyalinosis lesions in renal transplant biopsies: time-dependent complexity of interpretation","volume":"17","author":"Einecke","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2018.03.004_b0160","article-title":"A molecular biopsy test based on arteriolar under-hyalinosis reflects increased probability of rejection related to under-immunosuppression","author":"Einecke","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2018.03.004_b0165","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1111\/ajt.12478","article-title":"Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes","volume":"13","author":"Wiebe","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2018.03.004_b0170","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/TP.0b013e318203fd26","article-title":"C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation","volume":"91","author":"Yabu","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2018.03.004_b0175","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00467-016-3322-8","article-title":"Association of C1q-fixing DSA with late graft failure in pediatric renal transplant recipients","volume":"31","author":"Fichtner","year":"2016","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.humimm.2018.03.004_b0180","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2014040326","article-title":"Non-complement-binding de novo donor-specific anti-HLA antibodies and kidney allograft survival","volume":"27","author":"Guidicelli","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.humimm.2018.03.004_b0185","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.humimm.2016.01.018","article-title":"Current outcomes of chronic active antibody mediated rejection - A large single center retrospective review using the updated BANFF 2013 criteria","volume":"77","author":"Redfield","year":"2016","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2018.03.004_b0190","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1111\/ajt.14228","article-title":"Assessment of tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a potential treatment for chronic antibody-mediated rejection and transplant glomerulopathy in HLA-sensitized renal allograft recipients","volume":"17","author":"Choi","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2018.03.004_b0195","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/MNH.0000000000000070","article-title":"New insights regarding chronic antibody-mediated rejection and its progression to transplant glomerulopathy","volume":"23","author":"Schinstock","year":"2014","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.humimm.2018.03.004_b0200","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/TP.0000000000000908","article-title":"Peritubular Capillary Basement Membrane Multilayering in Renal Allograft Biopsies of Patients With De Novo Donor-Specific Antibodies","volume":"100","author":"de Kort","year":"2016","journal-title":"Transplantation"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885918300703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885918300703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:51:12Z","timestamp":1759319472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885918300703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0198885918300703"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2018.03.004","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlations between donor-specific antibodies and non-adherence with chronic active antibody-mediated rejection phenotypes and their impact on kidney graft survival","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2018.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}